ABAX Abaxis, Inc. (delisted)

ABAXIS to Report Financial Results for Third Quarter of Fiscal 2005 on Monday, January 31, 2005 UNION CITY, Calif., Jan. 21 /PRNewswire-FirstCall/ -- ABAXIS, Inc. (NASDAQ:ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the third fiscal quarter ended December 31, 2004. The call will be at 4:15 p.m. ET Monday, January 31, 2005. Participants can dial (877) 356-5706 or (706) 643-0580 to access the conference call, or can listen via a live Internet web cast, which can be found at http://www.abaxis.com/. A replay of the call is available by visiting http://www.abaxis.com/ for the next 30 days or by calling (800) 642-1687 or (706) 645-9291, access code 3553793, through February 4, 2005. ABAXIS develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 6.9 kilogram (15 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs, that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and perform multiple tests on whole blood, serum, or plasma samples. The system provides test results in less than 14 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer. DATASOURCE: ABAXIS, Inc. CONTACT: Clint Severson, Chief Executive Officer of ABAXIS, Inc., +1-510-675-6500; or Retail, Joe Dorame, or Institutional/Analysts, Joe Diaz, both of The RCG Group, +1-480-675-0400, for ABAXIS, Inc. Web site: http://www.abaxis.com/

Copyright